Skip to main content
Porto

PMMNG logo

  • Home
  • News
  • Our Meetings
    • Monthly PMMNG Meetings
    • Steering Committee Meetings
  • Myeloma Events
    • Upcoming Events
    • Archived Myeloma Events
  • Our Members
  • Miles for Myeloma
  • Resources
    • Myeloma Education Resources
    • Myeloma and Cancer Foundations
    • Regional Myeloma Support Groups
    • Publications and Newsletters
    • Cancer Support Networks
    • Treatments
    • Financial Assistance
    • Caregivers
  • Clinical Trials

Archived Events
  • IMF: Best of 2021 ASCO & EHA
  • MMRF: Latest Updates on Minimal Residual Disease (MRD)
  • July 2021 Meeting: Interpreting Lab Results
  • CancerCare: What’s New in Precision Medicine
  • CureTalks: CRISPR-edited Immune Cells Enhance Fight Against Blood Cancers
  • CancerCare: Transplantation as a Treatment Option for Blood Cancers
  • MMRF: ASCO Highlights Webinar
  • CancerCare: Caring for Your Loved One with Cancer
  • CancerCare: Managing the Side Effects of Immunotherapy
  • CancerCare: What’s New in Diagnostic Technologies for People Living with Blood Cancers

Myeloma Crowd: Multiple Myeloma Care in 2021

Myeloma Crowd logoWhat: Webcast audio (1:23:20)
When: Friday January 22, 2021 4:00 PM ET
Where: Web
Access audio and transcript

Tags
event
webcast
archived
clinical trials
ash
combination therapies
newly diagnosed myeloma
expected fda approvals
car-t
bispecific and trispecific antibodies
antibody drug conjugates
targeted inhibitors
mgus
smoldering myeloma
Dr. Robert Orlowski